<?xml version="1.0" encoding="UTF-8"?>
<p>Similar to the SARS-CoV, symptoms of COVID-19 infection at onset of the illness include fever, myalgia, fatigue, and cough, and more than half of patients developed dyspnoea. Some patients had radiographic ground-glass lung alterations, and lower than average circulating lymphocyte and platelet populations. To date, the global deaths reached 5746, and the fatality rate was estimated as 3.7% for COVID-19 virus (
 <uri xlink:href="https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd" xmlns:xlink="http://www.w3.org/1999/xlink">https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd</uri>), which is lower than that of SARS-CoV (10%) or MERS-CoV (37%).
 <sup>
  <xref ref-type="bibr" rid="ref1">1</xref>
 </sup> The major challenge of the coronavirus family and similar infectious agents is that no effective drugs or vaccine are available, and it may take many months for research and development.
</p>
